
Sign up to save your podcasts
Or


Investors back both OpenAI and Anthropic, breaking loyalty norms; Gilead acquires Arcellx for $7.8B; IQM targets $1.8B SPAC listing. AI rivalry heats up, biotech M&A surges, quantum moves toward commercialization, yet AI's economic impact is questioned. Get the latest tech & VC trends in 10 minutes. Tune in for more.
By AveryInvestors back both OpenAI and Anthropic, breaking loyalty norms; Gilead acquires Arcellx for $7.8B; IQM targets $1.8B SPAC listing. AI rivalry heats up, biotech M&A surges, quantum moves toward commercialization, yet AI's economic impact is questioned. Get the latest tech & VC trends in 10 minutes. Tune in for more.